Molecular cytogenetic alterations in the early stage at human bronchial epithelial cell carcinogenesis

Journal of Cellular Biochemistry

Volumn 67, Issue SUPPL. 28/29, 1997, Pages 74-80

  Dong, Xiang Yang ^a   Lu, Yong Jie ^a   Tong, Tong ^a   Wang, Yong Jun ^a   Guo, Su Ping ^a   Bai, Jin Feng ^a   Han, Nai Jun ^a   Cheng, Shu Jun ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Bronchial epithelium; Carcinogenesis; Chemoprevention; Lung cancer; Molecular cytogenetic alterations

Indexed keywords

BIOLOGICAL MARKER; PLASMID DNA; TUMOR MARKER;

ARTICLE; BRONCHUS MUCOSA; CANCER PREVENTION; CANCER STAGING; CELL IMMORTALIZATION; CHROMOSOME 14; CHROMOSOME 3P; CHROMOSOME 9P; CHROMOSOME TRANSLOCATION 8; CONTROLLED STUDY; CYTOGENETICS; EARLY CANCER; GENE ACTIVATION; HUMAN; HUMAN CELL; LUNG CARCINOGENESIS; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ANIMAL; BRONCHUS; CELL LINE; CHROMOSOME ABERRATION; GENETICS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MOUSE; PATHOLOGY; REVIEW;

ANIMALS; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TRANSFORMED; CHROMOSOME ABERRATIONS; HUMANS; LUNG NEOPLASMS; MICE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031398426     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1997)28/29+<74::AID-JCB8>3.0.CO;2-T     Document Type: Article

References (45)

1. Sobin LH (1982): The World Health Organization's Histological Classification of Lung Tumors: A comparison of the first and second editions. Cancer Detect Pre 5:391-406.
2. Boring C, Squires T, Tong T (1993): Cancer statistics. CA Cancer J Clin 43:7-26.
3. "Cancer Facts and Figures, 1994" (1994): Atlanta, GA: American Cancer Society.
4. Bishop JM (1987): The molecular genetics of cancer. Science 235:305-311.
5. Fearson ER, Vogelstein B (1990): A genetic model for colorectal tumori genesis. Cell 61:759-767.
6. Minna J, Maneckjiee R, D'Amico D, Bader S, Bodner S, Broers J, Buchhagen D, Carbone D, Chiba I, Curiel D, Fedorko J, Jensen S, Knutsen T, Linnoila I, Mitsudomi T, Nan M, Oie H, Pass H, Russeu E, Steinberg S, Takahashi T, Unger T, Viallet J, Whang-Peng J, Gazdar A (1991): Mutations in dominant and recessive oncogenes and the expression of opoid and nicotine receptors in the pathogenesis of lung cancer. In Harlow E (ed): "Origins of Human Cancer: Comprehensive Review." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, pp 781-789.
7. Lechner JF, LaVeck MA (1985): A serum free method for culturing normal human bronchial epithelial cells at clonal density. J Tissue Culture Methods 9:43-48.
8. Jetten AM, Shirley JE, Stoner GD (1986): Regulation of proliferation and differentiation of respiratory tract epithelial cells. Cell Biol Toxicol 2:53-62.
9. Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT, Brash DE, Park JB, Rhim JS, Harris CC (1988): Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 48:1904-1908.
10. Fang J, Cheng SJ, Mu JW (1992): Effect of growth factors on the growth of human bronchial epithelial cells and lung cancer cells (in Chinese). Carcinogen Teratogen Mutagen 4:7-10.
11. Seabright M (1971): A rapid banding technique for human chromosomes. Lancet 2:971-972.
12. Lu YJ, Dong XY, Guo SP, Ke Y, Cheng SJ (1996): Integration of SV40 at 12q23 in SV40-immortalized human bronchial epithelial cells. Carcinogenesis 17: 2089-2091.
13. Lu YJ, Dong XY and Guo SP, Zhang RG, Ke Y, Zhang LZ, Xu LH, Cheng SJ: 2q-, a nonrandom chromosomal abnormality in human nonsmall cell cancer. Carcinogenesis 17:1589-1593.
14. Lu YJ, Cheng SJ, Guo SP, Xu LH, Dong XY (1998): Detection by FISH of c-myc translocation in SV40T-transformed human bronchial epithelial cells and human lung cancer cell lines. Cancer Genet Cytogenet (in press).
15. Marcu KB, Bossne SA, Potel AJ (1992): Myc function and regulation. Annu Rev Biochem 6:809-860.
16. Sekido Y, Takahashi T, Makela TP, Dbata Y, Ueda R, Hida T, Hibi K, Shimokata K, Alitalo K, Takahashi T (1993): Complex intrachromosomal rearrangements in the process of amplification of the L-myc gene in small cell lung cancers and adjacent benign lung. Cancer Res 53:2379-2385.
17. Nichols J, Nimer SD (1992): Translocation factors, translocation, and leukemia. Blood 80:2953-2963.
18. Groce CM, Nowell PC (1985): Molecular basis of human B cell neoplasia. Blood 65:1-7.
19. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Handcock DC (1992): Induction of apoptosis in fribroblasts by c-myc protein. Cell 69:119-128.
20. Minnar JD (1993): The molecular biology of lung cancer pathogenesis. Chest 103:445s-456s.
21. Sato S, Nakamura Y, Tsuchiya E (1994): Differences of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 54:5652-5655.
22. Shiseki M, Kohono T, Nishikawa R, Sameshima Y, Mizoguchi H, Yokota J (1994): Frequent allelic losses on chromosome 2q, 18q and 22q in advanced non small cell lung carcinoma. Cancer Res 54:5643-5648.
23. Whang-Peng J, Kao SC, Lee EC, Bunn PA, Carney DN, Gazdar AF, Minna JD (1982): Specific chromosome defect associated with human small cell lung cancer; deletion 3p(14-23). Science 215:181-182.
24. Boldog FL, Gemmill RM, Wilke CM, Glover TW, Nillson AS, Chandrasekharappa SC, Brown RS, Li FP, Drabkin HA (1993): Positional cloning of the hereditary renal carcinoma chromosome translocation break point. Proc Natl Acad Sci USA 90:8509-8513.
25. LaForgia S, Morse B, Levy J, Barnea G, Cannizzaro LA, Li F, Nowell PC, Boghosian-Sell L, Flick J, Weston A, Harris CC, Drabkin H, Patterson D, Croce CM, Schlessinger J, Huebner K (1991): Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proc Natl Acad Sci USA 88:5036-5040.
26. Tsuchiya E, Nakamura Y, Weng SY, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T (1992): Allelotype of non small cell lung carcinoma comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 52:2478-2481.
27. Douglass EC, Valentine M, Etcubanas E, Parham D, Webber BL, Houghton PJ, Green AA (1987): A specific chromosome abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 45:148-155.
28. Haglund U, Juliusson G, Stellan B, Gahrton G (1994): Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. Blood 83:2637-2645.
29. Kohno T, Morishita K, Takano H, Shapiro DN, Yokota J (1993): Homozygous deletion at chromosome 2q33 in human small cell lung carcinoma identified by arbitrary primed PCR genomic fingerprinting. Oncogene 9:103-108.
30. Lukeis R, Ball D, Irving L, Garson OM, Hasthorpe S (1993): Chromosome abnormalities in nonsmall cell lung cancer pleural effusions: Cytogenetic indicators of disease subgroups. Genes Chromosomes Cancer 8:262-269.
31. Testa JR, Siegfried JM, Liu Z, Hunt JD, Feder MM, Litwin S, Zhou JY, Tagushi T, Keller S (1994): Cytogenetic analysis of 63 nonsmall cell lung carcinomas: Recurrent chromosome alterations amid frequent and wide spread genomic upheaval. Genes Chromosomes Cancer 11:178-194.
32. Olopade OI, Buchhagen DL, Malik K, Sherman J, Nobori T, Bader S, Nau MM, Gazdar AF, Minna JD, Diaz M (1993): Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 53:2410-2415.
33. Center R, Lukeis R, Dietzsch E, Gillespie M, Garson OM (1993): Molecular deletion of 9p sequences in non-small cell lung cancer and malignant mesothelioma. Genes Chromosomes Cancer 7:47-53.
34. Kamb A, Gruis N, Weaver-Feldhaus J, Liu QY, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson B, Skolinick MH (1994): A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
35. Washimi O, Nagatake M, Osada H, Veda R, Koshikawa T, Seki T, Takahashi T (1995): In vivo occurrence of P16(MST1) and p15(MST2) alterations preferentially in nonsmall cell lung cancer. Cancer Res 55:514-517.
36. Dong XY, Lu YJ, Guo SP, Gao SG, Cheng SJ (1996): The establishment and application of the dual color fluorescence in situ hybridization. Acta Academiae Medicinae Sinicae 18:319.
37. Serrano M, Hannon GJ, Beach D (1993): A new regulatory motif in cell cycle control causing specific inhibition of cyclinD/CDK4. Nature 366:704-707.
38. Kucherlapati R, Hwang SP, Shimizu N, McDougall JK, Botchan MR (1978): Another chromosomal assignment for a simian virus 40 integration site in human cells. Proc Natl Acad Sci USA 75:4460-4464.
39. Wright WE, Pereira-Smith OM, Shay JW. Reversible cellular senescence (1989): Implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 9:3088-3092.
40. Croce CM, Girardi AJ, Koprowski H (1973): Assignment of the T-antigen gene of simian virus 40 to human chromosome C-7. Proc Natl Acad Sci USA 70:3617-1620.
41. Kao C, Wu SQ, DeVries S, Reznikoff WS, Waldman FM, Resnikoff CA (1993): Carcinogen induced amplification of SV40 DNA insert at 9p12-21.1 associated with chromosome breakage, deletions, and translocations in human uroepithelial cell transformation in vitro. Genes Chromosomes Cancer 8:155-166.
42. Macaulay VM (1992): Insulin like growth factors and cancer. Br J Cancer 26:311-320.
43. Porcu P, Ferber A, Pietrzkowski Z, Roberts CT, Adamo M, Leroith D, Baserga R (1992): The growth stimulatory effect of simian virus 40T antigen requires the integration of insulin like growth factor I with its receptor. Mol Cell Biol 12:5069-5077.
44. Marx J (1993) Cell death studies yield cancer clue. Science 259:760-761.
45. Wang H, Chen L, Lin LM, Han MJ, Sun HX, Dai JW, Zhao CX, Cheng SJ (1996): Expression of transforming factor α and p53 in non small cell lung cancer by immunohistochemistry study. Chin J Oncol 18:84-87.